KEN MENDOZA

|

Building AI-powered medical tools from crisis, science, and invention

About Ken Mendoza

Ken Mendoza - AI Healthcare Founder

From systems architect to healthcare innovator, Ken Mendoza's journey began in the trenches of Silicon Valley tech companies, where he learned to build scalable systems and navigate the complex path from innovation to IPO. His technical foundation spans 25+ years of AI and software development, including leadership roles that culminated in a successful NASDAQ public offering.

The defining moment came during a deeply personal health crisis experienced by Ken's soulmate and the love of his life, Toni. Her medical journey—a relentless series of more than a hundred complex tests involving numerous specialists—ultimately led to the diagnoses of both a brain tumor and autoimmune disease, conditions that had previously gone undetected. This transformative experience exposed fundamental gaps in medical information management and care coordination, inspiring Ken's mission to revolutionize healthcare through AI and fueling the creation of MedAdvocate.

Today, Ken operates at the unique intersection of deep biomedical science, scalable software architecture, and defensible intellectual property. His work spans from computational immunology research exploring Polly Matzinger's Danger Theory to building AI-powered clinical tools.

With 5 patents in proteomics and extensive experience in drug target identification, Ken brings a rare combination of scientific rigor, technical execution, and venture leadership to the next generation of healthcare innovation.

5
Patents in Proteomics
25+
Years in AI/Tech
NASDAQ
IPO Success

Key Ventures

MedAdvocate.app

AI-Powered Medical Journey Companion built from lived experience navigating complex care. Consolidates symptoms, tests, and medical records into AI-accessible insights.

Learn More

DangerTheory.org

Computational Immunology Research Platform exploring Polly Matzinger's Danger Theory and its implications for context-aware clinical AI. Bridging biological pattern recognition with machine learning efficiency.

Learn More

Oregon Coast AI

SaaS & AI Automation Innovation Lab co-founded to develop commercial AI products and build a protected innovation portfolio. Focus on business automation and intelligent systems.

Learn More

Patents & Intellectual Property

5 Patents in Proteomics

Arbor Vita Corporation (2001-2008)

Focus Areas:

  • Drug target identification and validation
  • Molecular modeling and computational biology
  • Laboratory information management systems
  • Ischemic stroke research and therapeutics

Extensive portfolio of intellectual property developed during pioneering work in computational proteomics, establishing foundational technologies for AI-driven drug discovery and molecular analysis platforms.

Publications & Thought Leadership

The Thermodynamic Logic of Danger Theory

Proposes context-dependent immune activation is 10-100x more energy efficient than classical models.

2024

Epistemological Evolution of Immunological Theory: From Self-Recognition to Danger Detection

Traces the paradigm shift in immunology from self/non-self recognition to danger-based activation models.

2024

The Primal Image

Analyzes the "low road" neural pathway for high-contrast visual processing and its implications for AI perception.

2023

Technical Expertise

AI & Machine Learning

AI Guardrail Architectures Computer Vision NLP Systems LangChain Anthropic OpenAI Agent Frameworks

Biomedical & Research

Computational Biology Proteomics Immunological Theory Drug Target Identification Molecular Modeling Bioinformatics

Development & Infrastructure

Python JavaScript TypeScript Rust Go Cloudflare Workers Edge Computing PostgreSQL Supabase Chroma Pinecone Claude Code Cursor Windsurf

Leadership & Recognition

Co-founder, MedAdvocate

Created AI-powered medical journey platform

2025-Present

Co-founder, Oregon Coast AI

Building the next generation of commercial AI products with protected innovation portfolio

2024-Present

Independent Consultant & Creative Professional

Pursued independent consulting and creative ventures while maintaining expertise in technology and biomedical innovation

2008-2024

Bioinformatics & Systems Integration Lead

Arbor Vita Corporation

Developed 5 patents in proteomics and led drug target identification programs

2001-2008

Chief Technology Architect

Digital Lava Inc.

Led innovation resulting in successful NASDAQ IPO

1997-2001

Get In Touch

Are you an investor or strategic partner seeking to drive innovation in healthcare AI and biomedical technology? Join Ken Mendoza—AI Healthcare Founder, Biomedical Innovator, and Technology & IP Leader—in building the next generation of medical solutions. Let's shape the future of medicine together through impactful collaboration and sustainable growth.